Neoadjuvant immunotherapy plus chemotherapy in early triple-negative breast cancer: A meta-analysis of randomized controlled trials

被引：1
|
作者：
Pandy, J. G. P. [1 ]
Ordinario, M. V. C. [1 ]
Alcantara, M. J. E. [1 ]
Li, R. K. [1 ]
机构：
[1] St Lukes Med Ctr, Sect Med Oncol, Dept Med, Quezon City, Philippines
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.316
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
194P
引用
收藏
页码：S320 / S320
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant immunotherapy plus chemotherapy in early triple-negative breast cancer: A meta-analysis of randomized controlled trials
    Pandy, J. G. P.
    Alcantara, M. J. E.
    Ordinario, M. V.
    Li, R. K.
    ANNALS OF ONCOLOGY, 2020, 31 : S1245 - S1246
  • [2] Immunotherapy addition to neoadjuvant chemotherapy for early triple negative breast cancer: A systematic review and meta-analysis of randomized clinical trials
    Tarantino, Paolo
    Gandini, Sara
    Trapani, Dario
    Criscitiello, Carmen
    Curigliano, Giuseppe
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 159
  • [3] Adjuvant capecitabine for early triple-negative breast cancer: A meta-analysis of randomized controlled trials
    Liu, Mei
    Fang, Huiying
    Qian, Shengqiang
    ASIAN JOURNAL OF SURGERY, 2022, 45 (09) : 1748 - 1750
  • [4] Addition of immunotherapy to chemotherapy for metastatic triple-negative breast cancer: A systematic review and meta-analysis of randomized clinical trials
    Huo, Xingfa
    Shen, Guoshuang
    Liu, Zhen
    Liang, Yuhua
    Li, Jinming
    Zhao, Fuxing
    Ren, Dengfeng
    Zhao, Jiuda
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 168
  • [5] Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis
    Yuanfang Xin
    Guoshuang Shen
    Yonghui Zheng
    Yumei Guan
    Xingfa Huo
    Jinming Li
    Dengfeng Ren
    Fuxing Zhao
    Zhen Liu
    Zitao Li
    Jiuda Zhao
    BMC Cancer, 21
  • [6] Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis
    Xin, Yuanfang
    Shen, Guoshuang
    Zheng, Yonghui
    Guan, Yumei
    Huo, Xingfa
    Li, Jinming
    Ren, Dengfeng
    Zhao, Fuxing
    Liu, Zhen
    Li, Zitao
    Zhao, Jiuda
    BMC CANCER, 2021, 21 (01)
  • [7] Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
    Li, Yunhai
    Xing, Lei
    Li, Fan
    Liu, Hong
    Gan, Lu
    Yang, Dejuan
    Wang, Mengxue
    Yin, Xuedong
    Li, Hongyuan
    Ren, Guosheng
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] Effect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis
    Tian, Muyou
    Zhong, Yahua
    Zhou, Fuxiang
    Xie, Conghua
    Zhou, Yunfeng
    Liao, Zhengkai
    ONCOLOGY LETTERS, 2015, 9 (06) : 2825 - 2832
  • [9] Transcriptome Meta-Analysis of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy
    Zhang, Wei
    Li, Emma
    Wang, Lily
    Lehmann, Brian D. D.
    Chen, X. Steven
    CANCERS, 2023, 15 (08)
  • [10] Efficacy of carboplatin-based preoperative chemotherapy for triple-negative breast cancer A meta-analysis of randomized controlled trials
    Wang, Li-Yang
    Xie, Hua
    Zhou, Hang
    Yao, Wen-Xiu
    Zhao, Xin
    Wang, Yi
    SAUDI MEDICAL JOURNAL, 2017, 38 (01) : 18 - 23
12345